Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

2.
3.
4.

Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis.

Hondalus MK, Bardarov S, Russell R, Chan J, Jacobs WR Jr, Bloom BR.

Infect Immun. 2000 May;68(5):2888-98.

7.

Adenylylation and catalytic properties of Mycobacterium tuberculosis glutamine synthetase expressed in Escherichia coli versus mycobacteria.

Mehta R, Pearson JT, Mahajan S, Nath A, Hickey MJ, Sherman DR, Atkins WM.

J Biol Chem. 2004 May 21;279(21):22477-82.

8.

Independent transcription of glutamine synthetase (glnA2) and glutamine synthetase adenylyltransferase (glnE) in Mycobacterium bovis and Mycobacterium tuberculosis.

Hotter GS, Mouat P, Collins DM.

Tuberculosis (Edinb). 2008 Sep;88(5):382-9. doi: 10.1016/j.tube.2008.02.006.

PMID:
18440867
9.

The Mycobacterium tuberculosis protein serine/threonine kinase PknG is linked to cellular glutamate/glutamine levels and is important for growth in vivo.

Cowley S, Ko M, Pick N, Chow R, Downing KJ, Gordhan BG, Betts JC, Mizrahi V, Smith DA, Stokes RW, Av-Gay Y.

Mol Microbiol. 2004 Jun;52(6):1691-702.

10.

A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis.

Sambandamurthy VK, Wang X, Chen B, Russell RG, Derrick S, Collins FM, Morris SL, Jacobs WR Jr.

Nat Med. 2002 Oct;8(10):1171-4.

PMID:
12219086
11.

Functional analysis of GlnE, an essential adenylyl transferase in Mycobacterium tuberculosis.

Carroll P, Pashley CA, Parish T.

J Bacteriol. 2008 Jul;190(14):4894-902. doi: 10.1128/JB.00166-08.

12.
13.

Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine.

Jackson M, Phalen SW, Lagranderie M, Ensergueix D, Chavarot P, Marchal G, McMurray DN, Gicquel B, Guilhot C.

Infect Immun. 1999 Jun;67(6):2867-73.

14.

Mycobacterium tuberculosis WhiB3 interacts with RpoV to affect host survival but is dispensable for in vivo growth.

Steyn AJ, Collins DM, Hondalus MK, Jacobs WR Jr, Kawakami RP, Bloom BR.

Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3147-52.

16.

Low expression level of glnA1 accounts for absence of cell wall associated poly-l-glutamate/glutamine in Mycobacterium smegmatis.

Tripathi D, Kant S, Garg R, Bhatnagar R.

Biochem Biophys Res Commun. 2015 Mar 6;458(2):240-5. doi: 10.1016/j.bbrc.2015.01.079.

PMID:
25637529
17.

Auxotrophic vaccines for tuberculosis.

Guleria I, Teitelbaum R, McAdam RA, Kalpana G, Jacobs WR Jr, Bloom BR.

Nat Med. 1996 Mar;2(3):334-7.

PMID:
8612234
18.

Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates.

Smith DA, Parish T, Stoker NG, Bancroft GJ.

Infect Immun. 2001 Feb;69(2):1142-50.

19.

Construction and phenotypic characterization of an auxotrophic mutant of Mycobacterium tuberculosis defective in L-arginine biosynthesis.

Gordhan BG, Smith DA, Alderton H, McAdam RA, Bancroft GJ, Mizrahi V.

Infect Immun. 2002 Jun;70(6):3080-4.

20.

Immunogenicity and protection induced by Mycobacterium tuberculosis mce-2 and mce-3 mutants in a Balb/c mouse model of progressive pulmonary tuberculosis.

Aguilar LD, Infante E, Bianco MV, Cataldi A, Bigi F, Pando RH.

Vaccine. 2006 Mar 20;24(13):2333-42.

PMID:
16388878
Items per page

Supplemental Content

Support Center